Ratings
0
Nobody has rated this yet. Be the first!
Subject of
11
Rescue and propagation of fully retargeted oncolytic measles viruses
Phase I Trial of Intravenous Oncolytic Vaccinia Virus (GL-ONC1) with Cisplatin and Radiotherapy in Patients with Locoregionally Advanced Head and Neck Carcinoma
Immune responses following intrapleural administration of oncolytic SEPREHVIR in patients with malignant pleural mesothelioma.
Phase I/II trial of intravenous NDV-HUJ oncolytic virus in recurrent glioblastoma multiforme
Oncolytic virus therapy using genetically engineered herpes simplex viruses
For the Success of Oncolytic Viruses: Single Cycle Cures or Repeat Treatments? (One Cycle Should Be Enough)
History of oncolytic viruses: genesis to genetic engineering
From ONYX-015 to armed vaccinia viruses: the education and evolution of oncolytic virus development
Systemic efficacy of oncolytic adenoviruses in imagable orthotopic models of hormone refractory metastatic breast cancer
Exploiting tumor-specific defects in the interferon pathway with a previously unknown oncolytic virus
